PROGRESSIVE MYOCLONUS EPILEPSY ASSOCIATED WITH SACS GENE MUTATIONS
Download
Date
2016-08-01Source Title
Neurology GeneticsPublisher
LIPPINCOTT WILLIAMS & WILKINSAffiliation
Medicine (Austin & Northern Health)Metadata
Show full item recordDocument Type
Journal ArticleCitations
Nascimento, F. A., Canafoglia, L., Aljaafari, D., Muona, M., Lehesjoki, A. -E., Berkovic, S. F., Franceschetti, S. & Andrade, D. M. (2016). PROGRESSIVE MYOCLONUS EPILEPSY ASSOCIATED WITH SACS GENE MUTATIONS. NEUROLOGY-GENETICS, 2 (4), https://doi.org/10.1212/NXG.0000000000000083.Access Status
Open AccessAbstract
Pathogenic variants in the SACS gene (OMIM #604490) cause autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). ARSACS is a neurodegenerative early-onset progressive disorder, originally described in French Canadians, but later observed elsewhere.(1) Whole-exome sequencing of a large group of patients with unclassified progressive myoclonus epilepsies (PMEs) identified 2 patients bearing SACS gene mutations.(2) We detail the PME clinical features associated with SACS mutations and suggest the inclusion of the SACS gene in diagnostic screening of PMEs.
Export Reference in RIS Format